Updated every day

Venture Capital News

Funding rounds, launches, acquisitions and market moves — summarised by our AI from thousands of sources and linked to the startups and funds behind them. 42,052 stories in the archive.

Have news about your company?

Send us a funding round, launch or partnership. It goes out after a quick review.

Add news
Wednesday, July 31, 2024

The Rise of AI-Driven Automation: A New Era for Businesses

In the digital age, automation is no longer a luxury; it’s a necessity. Businesses are racing to adopt AI technologies to streamline operations, enhance customer interactions, and boost productivity. The integration of tools like ChatGPT…

Read more →

The Rising Threat of XDSpy: A Deep Dive into Cyber Espionage

In the shadows of the digital world, a new threat lurks. The cyber espionage group known as XDSpy has emerged as a formidable adversary, targeting companies in Russia and Moldova. Their latest tools, XDSpy.CHMDownloader and…

Read more →

Puerto Vallarta: A Cultural Tapestry Unfolds This Fall and Winter

Puerto Vallarta is a jewel on Mexico's Pacific Coast. As the rainy season fades, the city gears up for a vibrant fall and winter. Events bloom like flowers after a rain. From cultural celebrations to culinary delights, there's something…

Read more →

Mployer's 2024 Awards: A Beacon for Employee Benefits Consultants

In the bustling world of employee benefits, Mployer shines a spotlight on excellence. The fourth annual "Top Employee Benefits Consultant Awards" is not just a ceremony; it’s a compass guiding employers toward the best in the business…

Read more →

The Battle Against Movie Piracy: India’s New Frontline

In the vibrant world of Bollywood, where dreams are spun into celluloid, a darker shadow looms. Movie piracy, a relentless thief, steals the fruits of creativity. India, home to a bustling film industry, grapples with this menace. The…

Read more →

A New Dawn for Alzheimer's Treatment: The Promise of GLP-1 Drugs

In the realm of Alzheimer's research, a new player has emerged, and it’s wearing the familiar coat of a diabetes medication. Liraglutide, a glucagon-like peptide-1 (GLP-1) agonist, has shown potential in slowing cognitive decline, igniting…

Read more →

Follow the companies behind the news

Funding history, investors, teams and contacts of every startup and fund in the stories.